Focused on immunology-based therapies for infectious diseases, this biotech company reported a notable insider sale in recent filings.

The biotech group has struggled as a whole in 2025, but analysts say the innovation that has always supported the biotech ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Vir Biotechnology develops antibody and RNA-based therapies for infectious diseases, leveraging partnerships and a robust clinical pipeline.

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor ...

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that an abstract highlighting preclinical data from SG293, ...

SEATTLE, April 28, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Joining a cadre of other Bay Area biotech companies that are cutting staff, San Francisco-based Vir Biotechnology announced plans on Wednesday to lay off 141 workers. The layoff, disclosed in a WARN ...

View Anbio Biotechnology Class A NNNN stock quote prices, financial information, real-time forecasts, and company news from CNN.